K H Ketema1, J Raya2, T Workineh3, E Klinkenberg4, F Enquselassie5. 1. Oromia Regional Health Bureau, Addis Ababa, Ethiopia ; World Health Organization Country Office, Addis Ababa, Ethiopia. 2. Oromia Regional Health Bureau, Addis Ababa, Ethiopia. 3. Adama Hospital Medical Collage, Adama, Ethiopia. 4. KNCV Tuberculosis Foundation, The Hague, The Netherlands ; Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. 5. Addis Ababa University, Addis Ababa, Ethiopia.
Abstract
SETTING: Oromia Region, Ethiopia. OBJECTIVE: To investigate the effect of decentralised care on anti-tuberculosis treatment outcomes and identify factors affecting outcome among new smear-positive tuberculosis (TB) patients. DESIGN: This was a retrospective cohort study comparing patients treated in the community during the continuation phase with those managed throughout treatment in health facilities. Data were collected from TB registers and patient cards using a pre-tested data capture form. RESULTS: Of the 2226 new smear-positive TB patients registered from July 2010 to June 2012 who were included in the study, 1599 (72.6%) received treatment in health facilities, and the rest in the community. Overall treatment success was 94.7%. Patients treated in the community had comparable treatment success with those managed in health facilities (aOR 1.7, 95%CI 0.80-3.57). Missing doses (OR 0.22, 95%CI 0.08-0.55), supervision during the continuation phase (OR 2.6, 95%CI 1.34-5.05), positive sputum at month 2 (OR 0.07, 95%CI 0.04-0.13) and human immunodeficiency virus infection (OR 0.25, 95%CI 0.13-0.46) were independent predictors of treatment success. CONCLUSION: Overall treatment success is high in new smear-positive TB patients in Oromia. Patients receiving treatment in the community during the continuation phase have treatment success comparable with that of patients managed in health facilities.
SETTING: Oromia Region, Ethiopia. OBJECTIVE: To investigate the effect of decentralised care on anti-tuberculosis treatment outcomes and identify factors affecting outcome among new smear-positive tuberculosis (TB) patients. DESIGN: This was a retrospective cohort study comparing patients treated in the community during the continuation phase with those managed throughout treatment in health facilities. Data were collected from TB registers and patient cards using a pre-tested data capture form. RESULTS: Of the 2226 new smear-positive TB patients registered from July 2010 to June 2012 who were included in the study, 1599 (72.6%) received treatment in health facilities, and the rest in the community. Overall treatment success was 94.7%. Patients treated in the community had comparable treatment success with those managed in health facilities (aOR 1.7, 95%CI 0.80-3.57). Missing doses (OR 0.22, 95%CI 0.08-0.55), supervision during the continuation phase (OR 2.6, 95%CI 1.34-5.05), positive sputum at month 2 (OR 0.07, 95%CI 0.04-0.13) and human immunodeficiency virus infection (OR 0.25, 95%CI 0.13-0.46) were independent predictors of treatment success. CONCLUSION: Overall treatment success is high in new smear-positive TB patients in Oromia. Patients receiving treatment in the community during the continuation phase have treatment success comparable with that of patients managed in health facilities.
Entities:
Keywords:
community-based TB care; health facility; health post; new smear-positive TB; treatment outcome
Authors: Saidi Egwaga; Abdallah Mkopi; Nyagosya Range; Vera Haag-Arbenz; Amuri Baraka; Penny Grewal; Frank Cobelens; Hassan Mshinda; Fred Lwilla; Frank van Leth Journal: BMC Med Date: 2009-12-21 Impact factor: 8.775
Authors: Fred Lwilla; David Schellenberg; Honorath Masanja; Camilo Acosta; Claudia Galindo; John Aponte; Said Egwaga; Blasdus Njako; Carlos Ascaso; Marcel Tanner; Pedro Alonso Journal: Trop Med Int Health Date: 2003-03 Impact factor: 2.622
Authors: Hua Jianzhao; Susan van den Hof; Xu Lin; Qiu Yubang; Hou Jinglong; Marieke J van der Werf Journal: BMC Health Serv Res Date: 2011-05-11 Impact factor: 2.655
Authors: Mohammed A Yassin; Daniel G Datiko; Olivia Tulloch; Paulos Markos; Melkamsew Aschalew; Estifanos B Shargie; Mesay H Dangisso; Ryuichi Komatsu; Suvanand Sahu; Lucie Blok; Luis E Cuevas; Sally Theobald Journal: PLoS One Date: 2013-05-27 Impact factor: 3.240
Authors: Felix R Kayigamba; Mirjam I Bakker; Veronicah Mugisha; Ludwig De Naeyer; Michel Gasana; Frank Cobelens; Maarten Schim van der Loeff Journal: PLoS One Date: 2013-09-16 Impact factor: 3.240
Authors: E Klinkenberg; D Assefa; I D Rusen; R A Dlodlo; E Shimeles; B Kebede; D Fiseha; F Tsegaye; I Leimane; Y Teklai; R Dacombe; A Aseffa Journal: Public Health Action Date: 2014-12-21
Authors: Jonathan Izudi; Daniel Semakula; Richard Sennono; Imelda K Tamwesigire; Francis Bajunirwe Journal: BMJ Open Date: 2019-09-06 Impact factor: 2.692